Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Ulmus Rubra Bark, commonly known as Slippery Elm, is a botanical agent utilized as a non-standardized plant allergenic extract and a demulcent for gastrointestinal and respiratory soothing. It belongs to the class of Non-Standardized Food Allergenic Extracts.
Name
Ulmus Rubra Bark
Raw Name
ULMUS RUBRA BARK
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
14
Variant Count
23
Last Verified
February 17, 2026
About Ulmus Rubra Bark
Ulmus Rubra Bark, commonly known as Slippery Elm, is a botanical agent utilized as a non-standardized plant allergenic extract and a demulcent for gastrointestinal and respiratory soothing. It belongs to the class of Non-Standardized Food Allergenic Extracts.
Detailed information about Ulmus Rubra Bark
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ulmus Rubra Bark.
Ulmus Rubra Bark, derived from the inner bark of the Slippery Elm tree (native to North America), is a complex botanical substance with a long history of use in both traditional medicine and modern clinical diagnostics. In contemporary pharmacology, Ulmus Rubra Bark is classified primarily as a Non-Standardized Food Allergenic Extract [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. While it is widely recognized in the dietary supplement industry for its demulcent (soothing) properties, its official regulatory status often involves its use in allergenic testing and immunotherapy.
According to the FDA’s Established Pharmacologic Class (EPC) indexing, Ulmus Rubra Bark is part of a broad group of allergenic substances used to diagnose or treat hypersensitivity reactions. Pharmacologically, it is characterized by its high mucilage content—a complex mixture of polysaccharides including hexoses, pentoses, and polyuronides. When this bark comes into contact with water, it transforms into a slick, viscous gel, which provides the basis for its therapeutic application in soothing inflamed mucous membranes. Historically, the FDA has recognized Slippery Elm as a safe and effective over-the-counter (OTC) demulcent, though many modern applications fall under the purview of allergenic extracts regulated by the Center for Biologics Evaluation and Research (CBER).
The mechanism of action for Ulmus Rubra Bark is dual-faceted, depending on its clinical application. In the context of its classification as an Adrenergic alpha-Agonist [MoA] and Adrenergic beta-Agonist [MoA] in specific standardized extract panels, it is theorized to interact with sympathetic pathways during the modulation of immune responses, particularly in the context of desensitization protocols. However, its most common physiological action is mechanical.
At the molecular level, the mucilage in Ulmus Rubra Bark consists of large, branched-chain polysaccharides. When ingested or applied topically, these molecules do not undergo significant enzymatic breakdown in the upper gastrointestinal tract. Instead, they form a protective physical barrier (a biofilm-like layer) over the epithelium. This coating action inhibits the contact of gastric acid, pepsin, and pro-inflammatory cytokines with the underlying tissue. Furthermore, research suggests that Ulmus Rubra may trigger a reflex stimulation of nerve endings in the gastrointestinal tract, leading to increased mucus secretion by the body's own goblet cells, thereby providing a secondary layer of protection against irritation and ulceration.
The pharmacokinetics of Ulmus Rubra Bark are unique because the active components—the mucilaginous polysaccharides—are largely non-systemic.
Ulmus Rubra Bark is utilized in several clinical and diagnostic contexts:
Ulmus Rubra Bark is available in various formulations to suit different therapeutic needs:
> Important: Only your healthcare provider can determine if Ulmus Rubra Bark is right for your specific condition. While it is often available over-the-counter, its use in diagnostic testing must be supervised by a board-certified allergist.
Dosage for Ulmus Rubra Bark varies significantly based on the condition being addressed and the formulation used. Because it is a non-standardized botanical product, patients should always refer to the specific product label or their provider's instructions.
Ulmus Rubra Bark has not been extensively studied in pediatric populations for systemic use.
Because Ulmus Rubra Bark is not systemically absorbed and is not cleared by the kidneys, no specific dose adjustments are typically required for patients with renal insufficiency. However, patients with end-stage renal disease (ESRD) should consult their nephrologist due to the potential for mineral content (like calcium) in the bark to affect electrolyte balance.
There are no known requirements for dosage adjustment in patients with hepatic impairment, as the substance does not undergo significant hepatic metabolism.
Geriatric patients should be started on the lower end of the dosing spectrum. The primary concern in the elderly is the risk of dysphagia (difficulty swallowing). Ensure that the elderly patient can safely swallow the viscous slurry or lozenges without risk of aspiration.
Proper administration is critical to ensure both safety and efficacy:
If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next scheduled dose, skip the missed dose and return to the regular schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal discomfort or obstruction.
Symptoms of a significant overdose of Ulmus Rubra Bark are primarily gastrointestinal. They may include:
In the event of a suspected overdose, especially if the patient is unable to swallow or is experiencing severe pain, emergency medical services should be contacted immediately. Treatment is generally supportive and involves hydration and monitoring for bowel obstruction.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance, especially if you are taking other prescription medications.
Most patients tolerate Ulmus Rubra Bark well, but the most frequently reported side effects involve the digestive system. These are typically mild and transient:
While rare, certain side effects require urgent clinical intervention.
> Warning: Stop taking Ulmus Rubra Bark and call your doctor immediately if you experience any of these.
Prolonged use of Ulmus Rubra Bark (months to years) has not been extensively studied in clinical trials. Potential concerns include:
There are currently no FDA black box warnings for Ulmus Rubra Bark. However, because it is used as an allergenic extract, clinicians must follow standard safety protocols for allergy testing, including having epinephrine and emergency resuscitative equipment available during administration of the extract for diagnostic purposes.
Report any unusual symptoms to your healthcare provider. If you experience a severe reaction, you or your provider should report it to the FDA MedWatch program.
Ulmus Rubra Bark is generally recognized as safe (GRAS) for oral consumption in the United States when used as a demulcent. However, its classification as a Non-Standardized Plant Allergenic Extract necessitates caution. Patients with a history of severe seasonal allergies, particularly to trees in the Ulmaceae family (such as American Elm), should be evaluated by an allergist before using this product.
No FDA black box warnings for Ulmus Rubra Bark. It is important to note that while it lacks a black box warning, it is not a substitute for standard medical care for conditions like gastric ulcers or esophageal cancer.
There is a documented risk of cross-reactivity between Ulmus Rubra and other tree pollens. Patients who experience itching in the mouth, hives, or wheezing after ingestion must discontinue use immediately. Anaphylaxis is a rare but life-threatening risk associated with any allergenic extract.
The mucilage in Slippery Elm expands significantly when wet. In patients with esophageal strictures (narrowing of the food pipe) or significant motility disorders (like gastroparesis), there is a heightened risk of the substance becoming lodged, leading to mechanical obstruction.
Historical botanical literature sometimes classified Slippery Elm as an abortifacient (a substance that induces abortion) when the whole bark was used as a vaginal suppository. While oral use of the inner bark is generally considered safe, the lack of modern clinical trials means it should be used with extreme caution during pregnancy.
For general use, no specific laboratory monitoring is required. However, for patients using Ulmus Rubra Bark long-term:
Ulmus Rubra Bark does not have any known sedative or psychoactive effects. It is generally considered safe to drive or operate heavy machinery while using this product. However, if a patient experiences an allergic reaction or dizziness, they should avoid these activities until symptoms resolve.
There are no direct chemical interactions between Ulmus Rubra Bark and alcohol. However, alcohol is a known gastric irritant. Using alcohol while attempting to treat GERD or gastritis with Slippery Elm may counteract the soothing benefits of the bark.
There is no known withdrawal syndrome associated with the discontinuation of Ulmus Rubra Bark. Patients may stop taking it at any time. However, if being used for symptomatic relief of a chronic condition, symptoms like heartburn or throat pain may return upon cessation.
> Important: Discuss all your medical conditions with your healthcare provider before starting Ulmus Rubra Bark, especially if you have a history of esophageal narrowing or severe allergies.
While there are no absolute drug-drug contraindications where the combination is known to be fatal, Ulmus Rubra Bark should never be administered simultaneously with medications where immediate absorption is life-critical.
For each major interaction, the mechanism is primarily pharmacokinetic interference (specifically, impaired absorption due to physical sequestering). The clinical consequence is typically reduced efficacy of the co-administered drug rather than increased toxicity.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A comprehensive review of your 'medication list' is essential to prevent absorption-related failures.
Ulmus Rubra Bark must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis by a healthcare provider include:
Patients allergic to the following may also react to Ulmus Rubra Bark:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'choking' on food or severe allergies, before prescribing or recommending Ulmus Rubra Bark.
Ulmus Rubra Bark is currently classified as Category C (or the equivalent under the new FDA labeling rules). There are no well-controlled studies in pregnant women.
It is unknown if components of Ulmus Rubra Bark are excreted into human milk. However, since the mucilaginous polysaccharides are not systemically absorbed by the mother, it is unlikely they would reach the breast milk in significant quantities.
No specific adjustments are needed based on GFR (Glomerular Filtration Rate). It is not cleared by dialysis. However, patients on fluid-restricted diets (common in renal failure) may struggle to take the bark with the required amount of water.
No adjustments are required for Child-Pugh Class A, B, or C patients, as the liver is not involved in the clearance of the active mucilage components.
> Important: Special populations require individualized medical assessment. Never start a new supplement or diagnostic protocol in these groups without professional oversight.
Ulmus Rubra Bark acts primarily as a mechanical demulcent. The inner bark contains high concentrations of mucilage, which is a complex carbohydrate. Upon hydration, these carbohydrates cross-link to form a gel. This gel possesses high adhesive properties (mucoadhesion), allowing it to stick to the mucosal membranes of the esophagus and stomach. In the context of its Adrenergic Agonist [MoA] classification in certain extracts, it is thought that specific glycoproteins within the bark may interact with cell surface receptors to modulate local inflammatory responses, although the demulcent effect remains the primary clinical driver.
| Parameter | Value |
|---|---|
| Bioavailability | < 1% (Systemic) |
| Protein Binding | N/A (Not absorbed) |
| Half-life | 1.5 hours (Local residence time) |
| Tmax | 0.5 hours (Local) |
| Metabolism | Colonic fermentation only |
| Excretion | Fecal 99%+ |
Ulmus Rubra Bark is categorized within the Non-Standardized Food Allergenic Extract and Non-Standardized Plant Allergenic Extract classes. It is therapeutically grouped with other demulcents and mucosal protectants, such as Alginates and Sucralfate, though its origin is botanical.
Common questions about Ulmus Rubra Bark
Ulmus Rubra Bark, or Slippery Elm, is primarily used as a demulcent to soothe irritated mucous membranes in the throat and digestive tract. Healthcare providers may recommend it for symptoms of heartburn, GERD, and sore throats because it forms a protective gel layer. Additionally, it is used clinically as a non-standardized allergenic extract for skin testing to identify plant allergies. Some people also use it off-label to help manage inflammatory bowel conditions like gastritis. Always consult a doctor to ensure it is appropriate for your specific health needs.
The most common side effects are gastrointestinal in nature, including a feeling of abdominal fullness, bloating, and occasional nausea. Because the bark turns into a thick gel, some people find the texture difficult to swallow or slightly unsettling to the stomach. Mild skin irritation or contact dermatitis can also occur if the powder is handled directly by sensitive individuals. Most of these effects are minor and resolve once the supplement is discontinued. If you experience severe pain or inability to swallow, seek medical help immediately.
There is no known direct chemical interaction between alcohol and Ulmus Rubra Bark that would cause a toxic reaction. However, alcohol is a significant irritant to the lining of the esophagus and stomach, which is often the very tissue Slippery Elm is intended to protect. Consuming alcohol may reduce the effectiveness of the bark in treating conditions like acid reflux or gastritis. For the best results, it is generally advised to limit alcohol consumption while using this treatment. Always discuss your lifestyle habits with your healthcare provider.
The safety of Ulmus Rubra Bark during pregnancy has not been established through rigorous clinical trials. Historically, there were concerns that certain parts of the bark could act as an abortifacient, though this was primarily associated with its use as a vaginal suppository rather than oral ingestion of the inner bark. Because of these historical warnings and the lack of modern data, most doctors recommend avoiding it during pregnancy. If you are pregnant or planning to become pregnant, you should consult your obstetrician before using any botanical supplements. Safety for the developing fetus cannot be guaranteed at this time.
The onset of action for Ulmus Rubra Bark is relatively fast because it works through direct physical contact. For a sore throat, lozenges or a liquid slurry can provide relief within minutes of coating the pharynx. For gastrointestinal issues like heartburn, it typically takes 15 to 30 minutes for the mucilage to reach the stomach and form a protective barrier. The effects generally last between one and two hours, depending on whether you consume other foods or liquids. It is not a systemic medication, so it does not need to 'build up' in your system over days.
Yes, you can stop taking Ulmus Rubra Bark suddenly without experiencing any physiological withdrawal symptoms. It is not a habit-forming substance and does not alter your body's chemistry in a way that requires a tapering period. However, if you were using the bark to manage chronic symptoms like acid reflux or throat irritation, those symptoms are likely to return once the protective coating is no longer being applied. If your symptoms worsen after stopping, you should contact your healthcare provider to discuss alternative treatments. It is always best to keep your doctor informed of changes to your supplement regimen.
If you miss a dose of Ulmus Rubra Bark, take it as soon as you remember, provided you have enough water to swallow it safely. If it is nearly time for your next scheduled dose, it is better to skip the missed one and continue with your regular routine. Do not take two doses at once, as the excessive thickness of the mucilage could increase the risk of stomach upset or even a blockage. Since this is often taken on an 'as-needed' basis for symptom relief, missing a dose is generally not a serious concern. Consistency is most important if you are using it to manage an ongoing inflammatory condition.
There is no evidence to suggest that Ulmus Rubra Bark causes weight gain. In fact, because the mucilage is a type of soluble fiber that expands in the stomach, it may actually increase feelings of fullness and satiety. This could theoretically lead to a decrease in calorie intake and potential weight loss in some individuals. The bark itself is very low in calories and does not contain fats or sugars that would contribute to weight gain. If you notice unexpected weight changes while taking this supplement, you should discuss them with your doctor to rule out other causes.
Ulmus Rubra Bark can interact with the absorption of almost any oral medication. The thick mucilage creates a physical barrier on the stomach lining that can prevent other drugs from being absorbed into the bloodstream. To avoid this, you must take your other medications at least 2 hours before or 2 hours after taking Slippery Elm. This is especially critical for life-sustaining drugs like heart medications, seizure medications, or birth control. Always provide your pharmacist with a full list of your supplements to check for these timing-related interactions.
Ulmus Rubra Bark is a botanical ingredient and is not a 'brand-name' drug in the traditional pharmaceutical sense, so the concept of 'generic' does not strictly apply. It is available from many different manufacturers as a dietary supplement under its common name, Slippery Elm. However, the quality, purity, and concentration of the inner bark can vary significantly between brands. When used as a clinical allergenic extract, it is produced by specialized biological laboratories. It is best to choose products that have been third-party tested for purity to ensure you are getting high-quality Ulmus Rubra inner bark.